Gordon Ritter
Known title: DirectorCIK: 0001585857
Associated companies
Transaction History
| VEEV | ▼ Sell | Other | 250,000 | $0 | 9/1/2026 | View on chart |
| VEEV | ▼ Sell | Other | 15,585 | $0 | 9/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 541 | $0 | 9/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 298 | $0 | 6/1/2026 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 297 | $0 | 3/1/2026 | View on chart |
| VEEV | ▼ Sell | Other | 1,393 | $0 | 12/10/2025 | View on chart |
| VEEV | ▼ Sell | Other | 294 | $0 | 12/10/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 298 | $0 | 12/1/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 298 | $0 | 9/1/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 399 | $0 | 6/1/2025 | View on chart |
| VEEV | ▼ Sell | Other | 31,166 | $0 | 3/10/2025 | View on chart |
| VEEV | ▼ Sell | Other | 500,000 | $0 | 3/10/2025 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 398 | $0 | 3/1/2025 | View on chart |
| VEEV | ▼ Sell | Other | 1,501 | $0 | 12/19/2024 | View on chart |
| VEEV | ▼ Sell | Other | 316 | $0 | 12/19/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 399 | $0 | 12/1/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 399 | $0 | 9/1/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 352 | $0 | 6/1/2024 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 351 | $0 | 3/1/2024 | View on chart |
| VEEV | ▼ Sell | Other | 344 | $0 | 12/14/2023 | View on chart |
| VEEV | ▼ Sell | Other | 1,463 | $0 | 12/14/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 352 | $0 | 12/1/2023 | View on chart |
| VEEV | ▼ Sell | Other | 1,000,000 | $0 | 10/15/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 352 | $0 | 9/1/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 380 | $0 | 6/1/2023 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 379 | $0 | 3/1/2023 | View on chart |
| VEEV | ▼ Sell | Other | 1,218 | $0 | 12/12/2022 | View on chart |
| VEEV | ▼ Sell | Other | 286 | $0 | 12/12/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 380 | $0 | 12/1/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 380 | $0 | 9/1/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 229 | $0 | 6/1/2022 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 229 | $0 | 3/1/2022 | View on chart |
| VEEV | ▼ Sell | Other | 331 | $0 | 12/15/2021 | View on chart |
| VEEV | ▼ Sell | Other | 1,330 | $0 | 12/15/2021 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 230 | $0 | 12/1/2021 | View on chart |
| VEEV | ▲ Buy | Option Exercise | 229 | $0 | 9/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Veeva Gains Investor Attention Amid R&D Growth and AI Focus
Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.
Veeva Gains Investor Attention Amid R&D Growth and AI Focus. Veeva Systems is drawing investor interest as analysts note strong R&D growth and a positive outlook. The company has secured a major research partner that now uses its software as the default clinical platform, and a recent IQVIA deal expands its market reach. Large institutional investors are also increasing exposure to Veeva as part of an AI software play.